ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Digital twin validation and predictive value of delta radiomics based on tabular transformer for synergistic muscle imbalance in lumbar disc degeneration.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent methods struggle to quantify muscle synergistic imbalance and nonlinear interactions in Lumbar Intervertebral Disc Degeneration (LIDD). This study proposes a novel strategy combining "Delta Radiomics" with a Tabular Transformer deep learning architecture, aiming to improve the precision of early risk assessment.
methodsA retrospective analysis was conducted on L4-L5 MRI images from 663 subjects. Texture features of the Psoas Major (PM) and Erector Spinae (ES) were extracted, and (PM-ES)/ES was calculated as the "Delta Feature" to eliminate individual variation. An in silico digital twin simulation system was constructed to validate the physical sensitivity of these features. The predictive performance of the nonlinear Tabular Transformer model was compared with a traditional logistic regression model.
resultsIn silico experiments confirmed that Delta features possess superior "common-mode noise rejection" capabilities. In the early stage of degeneration (Step 20), when original features showed only weak changes, Delta features detected highly significant inter-group differences (P < 0.001). In the independent test set, the Tabular Transformer model demonstrated the best discriminative power with an AUC of 0.848 (95% CI: 0.781-0.916), outperforming the Combined linear model utilizing the same features (AUC = 0.804, P = 0.089) and single-modality models. Although the raw AUC improvement was marginal, Decision Curve Analysis (DCA) and quantitative calibration (Brier score = 0.145) showed that the Transformer model offered higher net clinical benefit and superior absolute risk estimation across a wider threshold range. Additionally, SHAP analysis revealed that the core features identified by the model highly aligned with the biomechanical compensation failure mechanisms set in the simulation, validating the model's decision logic.
conclusionDelta radiomics can sensitively capture microscopic muscle imbalance. Combined with the nonlinear modeling advantages of the Tabular Transformer architecture, this approach provides an objective, interpretable, and quantitative basis for the early non-invasive diagnosis and risk stratification of LIDD.
Indexed as
Identifiers
42850345What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.